StockNews.com Initiates Coverage on MediciNova (NASDAQ:MNOV)
Equities researchers at StockNews.com began coverage on shares of MediciNova (NASDAQ:MNOV – Get Free Report) in a report released on Saturday. The firm set a “hold” rating on the biopharmaceutical company’s stock. Separately, D. Boral Capital reiterated a “buy” rating and set a $9.00 target price on shares of MediciNova in a research report on […]
Equities researchers at StockNews.com began coverage on shares of MediciNova (NASDAQ:MNOV – Get Free Report) in a report released on Saturday. The firm set a “hold” rating on the biopharmaceutical company’s stock. Separately, D. Boral Capital reiterated a “buy” rating and set a $9.00 target price on shares of MediciNova in a research report on […]
